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Differences in the synthesis and kinetics of release of 
interleukin la , interleukin ip and tumor necrosis 
factor from human mononuclear cells*
Cell-associated and secreted interleukin l a  (IL la), IL 1(3 and tumor necrosis factor a 
(TNF-a), produced by human mononuclear cells (MNC) in vitro in response to 
lipopolysaccharide, were measured by radioimmunoassay. After 18 h of incubation, 
total production of IL la  in medium containing 1 % heat-inactivated serum was two- 
to-three times higher than IL 1(3. However, in the presence of 1% serum and 5% fresh 
plasma, IL la  and IL 1(3 were produced in similar amounts. Independent of the cul­
ture conditions, 90% of the IL l a  remained cell associated whereas 80% of IL 1(3 was 
extracellular. The kinetics of production and release of IL la ,  (3 and TNF-a were also 
studied. IL la  and TNF-a reached maximal levels within 6 h of stimulation, whereas 
IL 1(3 reached maximal levels between 12 and 16 h. I L la  remained primarily cell 
associated (80%) for the first 24 h. After 48 h, extracellular I L la  exceeded cell- 
associated levels. IL1(3 was primarily secreted (80%), appearing in the extracellular 
fluid within 6 h. TNF-a appeared in the extracellular fluid within 1 h of incubation, 
with <  10% cell associated at any time during the 48 h of incubation. Although the 
three cytokines share many biological activities, this study provides evidence that 
MNC IL la  is predominantly a cell-associated cytokine acting on a cell-cell basis, 
whereas IL 1(3 and TNF-a are secreted as paracrine mediators.
1 Introduction
Cytokines such as IL1 and TNF are products of activated 
mononuclear cells (MNC) and important mediators in infec­
tion, inflammation and immunological challenge [1, 2]. Two 
IL 1 peptides, IL l a  [3] and IL 1(3 [4], as well as TNF-a [5] have 
been cloned and studies using recombinant molecules have 
confirmed the biological activities attributed to these cytokines 
[1, 2, 6]. Although IL la ,  IL1(3 and TNF-a are different pro­
teins transcribed from different genes, they share many 
activities including fever [6- 8], induction of liver acute-phase 
protein synthesis [9], hemodynamic shock [10], and catabolic 
effects on bone and connective tissue [11, 12]. Further studies 
indicate that synergism can be demonstrated between TNF-a 
and the two forms of IL1 [10, 13, 14], and that all three 
cytokines may induce each other in vivo as well as in vitro [8, 
15, 16]. Because of these interactions, it is often difficult to 
discriminate between the effect of IL la ,  IL 1(3 or TNF-a in 
bioassays.
In the absence of exogenous stimulants, cytokines are not 
present in MNC. Activation of these cells leads to de novo 
synthesis of mRNA and new protein which is first detectable in 
the cytosol and subsequently secreted into the extracellular 
space. mRNA levels as measured by Northern blot analysis 
revealed that IL1(3 is the predominant IL1 form in human 
MNC [17]. On the protein level, intracellular production as 
well as release of biologically active IL1 has been demon-
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strated from lipopolysaccharide (LPS)-stimulated human 
MNC using the standard lymphocyte-activating factor assay 
[18]-
Investigations using gel chromatography and IEF demon­
strated differences in size as well as in pi between cell-associ- 
ated and extracellular IL 1 [19]. However, the relative amount 
of IL la  and IL1(3 in the two compartments, as detected by 
specific immunoreactivity, or a comparison with TNF-a has 
not been determined.
In the present study, we used recently developed radioim­
munoassays [20- 22] in order to quantify the differences 
between cell-associated and extracellular I L la  and IL 1(3 pro­
duction from LPS-stimulated human MNC under various test 
conditions. Furthermore, we compared the kinetics of IL la ,  
IL 1(3 and TNF-a production and determined their secretion 
from LPS-stimulated MNC.
2 Materials and methods
2.1 Preparation and incubation of human MNC
Heparinized human donor blood from healthy donors (10 U/ 
ml heparin) was diluted 1:3 in 0.15 M saline and MNC were 
separated over Ficoll-Hypaque (Ficoll Trennlosung, Biochrom 
KG, Berlin, FRG). MNC were washed three times in saline 
and suspended in ultrafiltered [23] Eagle’s MEM containing
2 mM L-glutamine, 100 U/ml penicillin, 100 [xg/ml streptomy­
cin, 10 mM Hepes (all from Whittaker M. A. Bioproducts 
Inc., Walkersville, MD) and 2% heat-inactivated (56°C for 
30 min) human AB serum from a single AB donor. Five 
hundred microliter aliquots of this MNC suspension (5 x 106 
cells/ml) were added to flat-bottom 24-well multititer plates 
(A/S Nunc, Roskilde, Denmark). Equal volumes of LPS (E . 
coli B : 55, Sigma, St. Louis, MO) in either MEM or MEM 
containing 10% fresh autologous human plasma were added. 
Following incubation at 37 °C in a humidified atmosphere with
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5% C 0 2, 50 \i\ of plasma was added to the plasma-free incuba­
tions in order to adjust the plasma content in all samples for 
the subsequent cytokine measurements. Fifty microliters of 
MEM was added to the plasma-containing wells in order to 
compensate the dilution factor. MNC SN were separated and 
centrifuged for 1 min at 13 000 x g in 4°C and the SN contain­
ing the extracellular IL1 were stored at - 7 0 °C until assayed. 
MNC pellets in the wells were resuspended in MEM contain­
ing 5% plasma and 1% heat-inactivated AB serum (1 ml each) 
and exposed to three freeze-thaw cycles in order to lyse the 
cells and obtain the cell-associated pool of cytokines. These 
samples were also frozen at -70  °C until assay. Control experi­
ments in which known amounts of IL la  and IL 1(3 were added 
to MNC lysates, then frozen and thawed three times, indicated 
that this process did not destroy the immunoreactivity of the 
cytokines.
In the first set of experiments, MNC incubations with various 
LPS concentrations were performed for 18 h in the presence 
or absence of plasma. The LPS dose-response curve as well as 
the influence of added plasma were studied. In the second set 
of experiments, MNC were stimulated with a single concentra­
tion of LPS (500 ng/ml) in the presence of 1% serum and 5% 
plasma and the time-course of IL 1 and TNF production and 
release was determined. In order to study whether the kinetics 
of cytokine production and/or release are influenced by the 
presence of LPS, we compared the effect of constant LPS 
presence with that of a 2-h exposure to LPS stimulation on 
MNC IL1 and TNF-a production. For this purpose, MNC in 
MEM containing 1% serum, 5% plasma and 500 ng/ml LPS 
were incubated at 37°C in multititer plates. After 2 h, LPS- 
containing cell SN were removed from every second well and 
adhering cells washed by adding and removing fresh MEM 
containing 1% serum and 5% plasma three times. After this, 
incubation in fresh medium was continued for various time 
periods. In parallel MNC cultures, 500 ng/ml LPS was con­
stantly present during incubation.
(A)
2.2 Cytokine measurement
Extracellular and cell-associated levels of immunoreactive 
IL la ,  IL 1(3 and TNF-a were measured using specific RIA 
[20-22]. All samples were diluted 1:5 in BSA buffer (0.25% 
BSA, Sigma) and assayed in duplicates.
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Figure 1. Dose response of endotoxin-induced I L l a  (■) and IL1(3 
(□) production from MNC during 18 h of incubation in tissue culture 
medium containing 1% serum. (A) Total (cell associated + extracellu­
lar); (B) cell-associated levels, and (C) extracellular levels. Each bar 
represents the mean of four experiments ± SEM.
partment we detected 5-10 times more IL lp  than IL la  
(Fig. 1C). Comparing the results of all these studies it is clear 
that after 18 h of incubation, 80% of the total IL 1(3 production 
is secreted whereas 90% of the IL la  remains cell associated.
3 Results
3.1 Dose response of LPS-induced MNC IL la  and IL 1(J 
production: the influence of 5% plasma
The total IL1 production (cell-associated plus extracellular) 
from LPS-stimulated MNC in 1% serum is depicted in 
Fig. 1A. In response to LPS concentrations of 0.5-500 ng/ml, 
IL 1 production is dose dependent, and MNC produce two to 
three times more IL la  than IL1(3 during 18 h of incubation. 
By 5 |ig/ml LPS, the maximum dose we used, equal amounts of 
IL la  and IL 1(3 were induced, although the total IL 1 produc­
tion was decreased compared to the incubations with 500 ng/ 
ml LPS. This decrease may be due to cyclooxygenase products 
induced by high-dose LPS [24]. Cell-associated and extracellu­
lar levels of IL1 are also depicted. Independent of the LPS 
dose, the cell-associated samples contained 5-10 times more 
I L la  than IL 1(3 (Fig. IB), whereas in the extracellular com-
IL 1 production from LPS-stimulated MNC in the presence of 
1% serum and 5% plasma is depicted in Fig. 2. Compared to 
results obtained in the absence of plasma, total IL la  and IL 1(3 
production is enhanced by a factor of 10 in response to low- 
dose LPS (0.5 ng/ml) and by a factor of 3-5 when 5-5000 ng/ 
ml LPS are used as stimuli. In response to 0.5 ng/ml LPS, 
MNC produce three times more IL la  than IL 1(3 (Fig. 2A). In 
contrast, using higher LPS concentrations (0.5 and 5 (ig/ml) in 
the presence of 1% serum and 5% plasma during incubation, 
I L la  and IL 1(3 are produced in similar amounts. Most of the 
I L la  remains cell associated and the IL1(3 is secreted, as 
observed previously in the absence of plasma. As depicted in 
Fig. 2B, the cell-associated samples contain 5-10 times more 
IL l a  than IL 1(3 and MNC secrete 5-10 times more IL 1(3 than 
I L la  (Fig. 2C). Similar to the plasma-free incubations, 
80%-90% of total I L la  remains cell associated at all concen­
trations of LPS, whereas 80% of total IL 1(3 is found in the 
extracellular compartment after 18 h of incubation.
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Figure 2. Dose response of I L l a  and IL 1 p production from MNC 
during 18 h of incubation in tissue culture medium containing 1% 
serum, 5% autologous plasma and various concentrations of LPS. (A) 
Total IL1 (cell associated-I-extracellular); (B) cell-associated levels; 
(C) extracellular concentrations. Each bar represents the mean of four 
experiments ± SEM.
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3.2 Kinetics of LPS-induced MNC IL la ,  IL 10 and TNF-a 
production and release
MNC from two donors were stimulated with 500 ng/ml LPS in 
the presence of 1% heated AB serum and 5% autologous 
plasma and incubated for various time periods at 37 °C. MNC 
SN as well as cell lysates were assayed for extracellular and 
cell-associated levels of IL la ,  IL1(3 and TNF-a after 1, 2, 6, 
16, 20, 24 and 48 h of incubation (Figs. 3 and 4). In both 
experiments, cell-associated IL la  is detectable within 2 h, 
increases with time and reaches a plateau at maximal levels of 
10 ng/ml within 6 h (Figs. 3A and 4A). After 24 h of MNC 
incubation, cell-associated concentrations of IL la  start to 
decrease and are lower (2-4 ng/ml) in the 48-h samples. 
Extracellular concentrations of IL la  are detectable within 6 h 
and increase to exceed cell-associated levels after 48 h of incu­
bation (Figs. 3A and 4A).
The time-course of IL 1(3 production and release is shown in 
Figs. 3B and 4B. Like IL la ,  cell-associated IL 1(3 concentra­
tions are maximal (3-5 ng/ml) within 6 h and start to decrease
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Figure 3. Time course of IL la ,  IL Iß and TNF-a production from 
human MNC incubated with 500 ng/ml LPS in MEM containing 1% 
serum and 5% autologous plasma. Cell-associated and extracellular 
cytokine levels were measured after 1, 2, 6, 16, 20, 24 and 48 h. The 
results depict a single donor. (A) IL la ;  (B) IL lß; (C) TNF-a.
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after 20-24 h of incubation. In contrast to the IL la  measure­
ments, extracellular amounts of IL lß exceed cell-associated 
levels of the 6-h samples and reach maximal concentrations 
(10-15 ng/ml) within 16 h of MNC incubation.
Secreted TNF exceeds cell-associated levels in the first sample 
taken after 1 h of incubation (Figs. 3C and 4C). Cell-associ­
ated TNF-a is less than 10% of total at all time points. 
Extracellular TNF-a increases with time, reaches maximal 
levels within 6-16 h (7-10 ng/ml) and decreases thereafter to 
concentrations of 3-5 ng/ml during the following time period.
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We next compared the effect of a 2-h LPS stimulation vs. 
constant LPS stimulation on cytokine production and release 
(Fig. 5). Once again the culture medium contained 1 % serum 
plus 5% autologous plasma and the LPS concentration we 
used was 500 ng/ml. MNC incubation was performed for 2, 4, 
6, 12, 24 and 48 h, and cell-associated as well as extracellular 
concentrations of IL la ,  IL 1(3 and TNF-a were measured.
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Figure 4. The experimental design is the same as that shown in Fig. 3 
but using the MNC of another donor.
Figure 5. Time course of IL la ,  IL1(3 and TNF-a production from 
human MNC incubated with 500 ng/ml LPS in MEM containing 1% 
serum and 5% autologous plasma. MNC incubated continually in LPS 
is compared to LPS stimulation for 2 h. Cell-associated and extracellu­
lar cytokine levels were measured after 2, 4, 6, 12, 24 and 48 h. (A) 
IL la ;  (B) ILIP; (C) TNF-a.
Although at several time points values for all three cytokines 
are less following a 2-h LPS stimulation than after constant 
LPS stimulation, the time courses of cytokine production and 
release are the same. Most of the IL la  remains cell associated 
until 48 h of incubation (Fig. 5A). In contrast, 50% of the 
IL 1(3 is already secreted after 6 h and extracellular concentra­
tions reach maximum within 12 h (Fig. 5B). As shown in 
Fig. 5C, cell-associated concentrations of TNF-a are very low 
or not detectable in the samples. Extracellular TNF-a is maxi­
mal after 12 h of incubation, independent of the time of LPS 
stimulation (2 h or constant) and decreases to lower levels 
measured in the 24-h and 48-h samples.
4 Discussion
We have demonstrated differences in the amount of cell- 
associated and extracellular IL la ,  IL 1(3 and TNF-a produced 
in vitro by human MNC stimulated with LPS. First we com­
pared cell-associated and extracellular IL la  and IL 1(3 produc-
tion in response to various concentrations of LPS and tested 
the influence of 5% autologous plasma present during 18 h of 
incubation. Second, we investigated the kinetics of production 
and release of IL la ,  IL 1(3 and TNF-a from human MNC 
stimulated with 500 ng/ml LPS in the presence of 1% AB 
serum and 5% plasma.
In the presence of 1% AB serum, LPS induces more total 
I L la  than IL 1(3. This is a surprising new finding since other 
authors studying mRNA levels found more mRNA for IL 1(3 
than for IL la  in LPS-stimulated MNC [17]. Therefore, trans­
lation following transcription seems to be regulated or at least 
influenced differently for the two forms of IL1. Compared to 
plasma-free incubations, in the presence of 5% plasma, both 
IL la  and IL 1(3 production as well as release are increased. 
The enhancing effect of plasma is more effective on IL 1(3 than 
on IL la  synthesis, so that the addition of plasma to the MNC 
incubation leads to the production of equal amounts of IL la  
and IL 1(3. The mechanism by which plasma enhances LPS- 
induced IL1 production is unknown. Although a synergism
between the complement component C5a and LPS has been 
described [25], the amount of C5a present in a solution con­
taining only 5% plasma is unlikely to be alone responsible for 
the observed plasma effect on IL1 production. Therefore, 
other factors seem to be involved, i.e. thrombin or platelet 
factors like serotonin which may also act synergistically with 
LPS on MNC IL1 production [26].
Regardless of culture conditions, 80% of IL 1(3 is secreted into 
the extracellular compartment whereas 90% of IL la  remains 
cell associated after 18 h of LPS stimulation. These results are 
supported by other authors who reported intracellular IL1 
activity, 90% of which had a pi of 5.5 and therefore was IL la  
[18]. Secreted amounts of both IL la  and IL 1(3 are LPS dose 
dependent, whereas the cell-associated IL1 production seems 
to be dose independent as long as the stimulating LPS concen­
tration exceeds a threshold (5 ng/ml without plasma, 0.5 ng/ml 
with plasma).
Transcription and protein synthesis seems to be regulated 
similarly for IL la  and IL 1(3. In contrast, IL 1 release into the 
extracellular space seems to be controlled differently for the a 
and (3 forms of this cytokine. Although the absence of a signal 
peptide on the two IL 1 molecules indicates that both 
cytokines might not be typical secretory proteins, our results 
suggest that IL 1(3 is predominantly secreted whereas IL la  
remains cell associated.
The time-course studies of cytokine production and release 
from LPS-stimulated MNC confirm the results of the dose- 
response study with respect to the compartmentalization of 
IL1. Most of the I L la  remains cell associated up to 24 h, 
whereas IL 1(3 is found predominantly in the extracellular com­
partment within 6 h. Previous studies have suggested that plas- 
min [27] and other serine proteases [28] influence the amount 
of IL 1(3 secreted into the extracellular fluid and the present 
results are consistent with this finding, since the fresh plasma 
present during incubation probably contains proteases. A 
recent study suggests that the phosphorylation of the intracel­
lular precursor of IL la  may facilitate the processing and 
release of I L la  and that this phosphorylation does not take 
place on IL 1(3 [29]. However, our results demonstrate IL 1(3 as 
the predominantly secreted form of IL1 whereas IL la  
remains cell associated. Therefore, in the mechanism of secre­
tion, phosphorylation seems to be less important for IL 1(3 
than processing of the precursor by other factors like proteases 
[28].
We also measured TNF-a levels in the time course experi­
ments. In contrast to IL 1(3, the majority of IL la  is present in 
the extracellular fluid already after 1 h of incubation. Trans­
cription and translation on the one hand and transport into the 
extracellular space on the other hand seem to be closely linked 
for TNF-a. The differences in secretion kinetics for TNF-a 
compared to the IL 1 peptides could be explained by the differ­
ent molecular structure of this cytokine. In contrast to both 
forms of IL1, TNF-a possesses a typical signal peptide for 
cleavage and transport [5], suggesting that TNF-a is a se­
cretory peptide. Recent studies, however, claim that TNF-a is 
also active as a cell-associated molecule [30].
We did not differentiate between cytosolic and membrane- 
bound IL 1 or TNF in this study. Since no ultracentrifugation 
was performed before measurement of cell-associated 
cytokines after the three freeze-thaw cycles, these samples
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may contain both cytosolic and membrane-bound IL 1 and/or 
TNF-a.
Several studies provide evidence that both forms of IL 1 exist 
as cytosolic as well as membrane-bound molecules. Conlon et 
al. demonstrated membrane-bound IL la  on human MNC 
after 18 h of LPS stimulation [31]. Studies using anti-ILlß 
antibodies identified cell surface IL1 as the IL lß molecule 
[32]. Cytosolic IL 1 has been specifically identified as IL la  by 
IEF [18] and also as IL lß by immunoprecipitation [28]. Sisson 
et al. [33], who fractionated the cell-associated compartments 
of immunoreactive cytokines in MNC stimulated with GM- 
CSF, found most of the cell-associated IL la  and IL lß in the 
cytosolic compartment.
Like LPS, GM-CSF also induced TNF-a in MNC, 90% of 
which was secreted into the extracellular compartment. Most 
of the low amount of cell-associated TNF-a was in the 
cytosolic compartment [33]. In contrast, a recent study 
described TNF acting as a cytotoxic membrane-bound protein 
[34]. However, these studies were done with cell lines which 
may differ from MNC. According to our results, LPS-stimu­
lated MNC seem to process and release TNF-a very readily. 
Although we did not attempt to identify membrane-bound 
TNF-a in this study, our data suggest that this is a very small 
amount of the total TNF-a produced by MNC following LPS 
stimulation.
We thank Dr Alan Shaw for providing human recombinant ILlß,  
I L l a  and TNF-a, and Herle Lindemann, Anke Palm, Dr Takashi 
Ikejima, Scott Orencole and Reza Ghorbani for their help and technical 
assistance.
Received April 1, 1989.
Cytokine synthesis and kinetics 1535
5 References
1 Dinarello, C. A., FASEB J. 1988. 2: 108.
2 Beutler, B. and Cerami, A., N. Engl. J. Med. 1987. 316: 379.
3 Lomedico, P. T., Gubler, U., Heilman, C. P., Dukovich, M., Giri, 
J. G., Pan, Y-C. E., Collier, K., Semionow, R., Chua, A. O. and 
Mizel, S. B., Nature 1984. 312: 458.
4 Auron, P. E., Webb, A. C., Rosenwasser, L. J., Mucci, S. F., 
Rich, A., Wolff, S. M. and Dinarello, C. A., Proc. Natl. Acad. 
Sei. USA 1984. 81: 7907.
5 Pennica, D., Nedwin, G. E., Hayflick, J. S., Seeburg, P. H., 
Derynck, R., Palladino, M. A., Kowr, J. W., Aggarwal, B. B. and 
Goeddel, D. V., Nature 1984. 312: 724.
6 Dinarello, C. A., Cannon, J. G., Mier, J. W., Bernheim, H. A., 
LoPreste, G., Lynn, D. L., Love, R. N., Webb, A. C., Auron, P. 
E., Reuben, R. C., Rieh, A., Wolff, S. M. and Putney, S. D., 
J. Clin. Invest. 1986. 77: 1734.
7 Dinarello, C. A., Year Immunol. 1986. 2: 68.
8 Dinarello, C. A., Cannon J. G., Wolff, S. M., Bernheim, H. A., 
Beutler, B., Cerami, A., Figari, I. S., Palladino, M. A. and 
O’Connor, J. V., J. Exp. Med. 1986. 163: 1433.
9 Perlmutter, D. H., Dinarello, C. A., Punsal, P. I. and Colton, H. 
R., 7. Clin. Invest. 1986. 75.-1349.
10 Okusawa, S., Gelfand, J. A., Ikejima, T., Connolly, R. J. and 
Dinarello, C. A., J. Clin. Invest. 1988, in press.
11 Dewhirst, F. E., Stashenko, P. P., Mole, J. E. and Tsurumachi, 
T., J. Immunol. 1985. 135: 2562.
12 Krane, S. M., Dayer, J. M., Simon, L. S. and Byrne, S., Collagen 
Relat. Res. 1985. 5: 99.
13 Mandrup-Poulsen, T., Bendtzen, K., Dinarello, C. A. and Nerup, 
J., J. Immunol. 1987. 139: 4077.
1536 G. Lonnemann, S. Endres, J. W. M. Van der Meer et al Eur. J. Immunol. 1989.19: 1531-1536
14 Elias, J. A., Gustillo, M., Baeder, W. and Freundlich, B., J. Im­
munol. 1987. 138: 3812.
15 Dinarello, C. A., Ikejima, T., Warner, S. J. C., Orencole, S. F., 
Lonnemann, G., Cannon, J. G. and Libby, P., J. Immunol. 1987. 
139: 1902.
16 Libby, P., Ordovas, J. M., Auger, K. R., Robbins, A. H., Birinyi, 
L. K. and Dinarello, C. A., Am. J. Pathol. 1986. 124: 179.
17 Demczuk, S., Baumberger, C., Mach, B. and Dayer, J. M., 
J. Mol. Cell. Immunol. 1987. 3: 255.
18 Lasfargues, A., Ledur, A., Charon, D., Szabo, L. and Chaby, R., 
J. Immunol. 1987. 139: 429.
19 Lepe-Zuniga, J. L., Zigler, J. S., Jr., Zimmerman, M. L. and 
Gery, I., Mol. Immunol. 1985. 22: 1387.
20 Lisi, P. J., Chu, C. W., Koch, G. A., Endres, S., Lonnemann, G. 
and Dinarello, C. A., Lymphokine Res. 1987. 6: 229.
21 Lonnemann, G., Endres, S., Van der Meer, J. W. M., Ikejima, T., 
Cannon, J. G. and Dinarello, C. A., Lymphokine Res. 1988. 7: 75.
22 Van der Meer, J. W. M., Endres, S., Lonnemann, G., Cannon, J. 
G., Ikejima, T., Okusawa, S., Gelfand, J. A. and Dinarello, C. 
A., J. Leukocyte Biol. 1988. 43: 216.
23 Dinarello, C. A., Lonnemann, G., Maxwell, R. and Shaldon, S., 
J. Clin. Microbiol. 1987. 25: 1233.
24 Knudsen, P. J., Dinarello, C. A. and Strom, T. B., J. Immunol. 
1988. 137: 3189.
25 Okusawa, S., Dinarello, C. A., Yancey, K. B., Endres, S., Law- 
ley, T. J., Frank, M. M., Burke, J. F. and Gelfand, J. A., J. Im­
munol. 1987. 139: 2635.
26 LoPreste, G. and Dinarello, C. A., Lymphokine Res. 1987. 6: 72 
(Abstract).
27 Matsushima, K., Taguchi, M., Kovacs, E. J., Young, H. A. and 
Oppenheim, J. J., J. Immunol. 1986. 136: 2883.
28 Auron, P. E., Warner, S. J. C., Webb, A. C., Cannon, J. G., 
Bernheim, H. A., McAdam, K. J. P. W., Rosenwasser, L. J., 
LoPreste, G., Mucci, S. F. and Dinarello, C. A., J. Immunol.
1987. 138: 1447.
29 Kobayashi, Y., Appella, E., Yamada, M., Copeland, T. D., 
Oppenheim, J. J. and Matsushima, K., J. Immunol. 1988. 140: 
2279.
30 Decker, T., Lohmann-Mathes, M. L. and Gifford, G. E., J. Im­
munol. 1987. 138: 957.
31 Conlon, P. J., Grabstein, K. H., Alpert, A., Prickett, K. S., 
Hopp, T. P. and Gillis, S., J. Immunol. 1987. 139: 98.
32 Bayne, E. K., Rupp, E. A., Limjuco, G., Chin, J. and Schmidt, 
J. A., J. Exp. Med. 1986. 163: 1267.
33 Sisson, S. D. and Dinarello, C. A., Blood 1988. 72: 1368.
34 Kriegler, M., Perez, C., DeFay, K., Albert, I. and Lu, S. D., Cell
1988. 53: 45.
